Streetbeat News

Earnings

SRPT

Sarepta Therapeutics' shares dropped following the announcement of their Q4 financial results. Despite the decline, Needham continues to recommend a Buy rating on the stock, albeit with a reduced price target from $169 to $166.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 6:17 pm

MQ

Marqeta shares are trading lower following the announcement of their Q4 results.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 6:13 pm

NFE

New Fortress Energy's stock is trading higher following the announcement of their Q4 results, which surpassed expectations.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 6:13 pm

PSTG

Pure Storage, Inc. (NYSE:PSTG) reported strong Q4 results, surpassing consensus estimates with adjusted earnings of 50 cents per share and sales of $789.8 million. The company also provided optimistic Q1 revenue guidance of $680 million, exceeding analyst expectations. Following these results, several analysts raised their price targets on PSTG, contributing to a 22.3% increase in its stock price to $51.52.

Portfolio Pulse from Avi Kapoor

February 29, 2024 | 6:12 pm

HAYW

Hayward Holdings shares are trading higher following the announcement of their Q4 results, which exceeded expectations.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 6:12 pm

NARI

Inari Medical's shares dropped following mixed Q4 results and the announcement of a DOJ investigation. Additionally, Piper Sandler downgraded the stock to Neutral.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 6:09 pm

CELH

Celsius Holdings' shares surged following the announcement of their Q4 financial results, which exceeded market expectations.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 6:09 pm

NTES

NetEase shares are trading lower following the announcement of their Q4 financial results, which did not meet expectations.

Portfolio Pulse from Benzinga Newsdesk

February 29, 2024 | 6:05 pm

SHOO

Seven analysts have recently shared their views on Steven Madden (NASDAQ:SHOO), all maintaining an indifferent stance with no changes in the past 30 days. The average 12-month price target for SHOO has been raised to $41.43 from $38.50, indicating a positive outlook. Steven Madden's financial performance shows a slight revenue decline but strong profitability metrics, including an impressive net margin and ROE.

Portfolio Pulse from Benzinga Insights

February 29, 2024 | 6:02 pm

FREY

FREYR Battery, Inc. (NYSE:FREY) reported a Q4 FY23 adjusted EPS loss of $(0.13), beating consensus estimates but still showing a net loss of $(24.2) million compared to a net income of $25.3 million a year earlier. Despite the loss, the company has a strong cash position of $275.7 million and plans to focus on achieving production with full automation and developing Giga America with DOE Title 17 loan program support by H1 2024. Shares fell by 5.42% to $1.57.

Portfolio Pulse from Lekha Gupta

February 29, 2024 | 6:01 pm